Korro Bio
6 articles with Korro Bio
-
Korro Bio Chief Executive Officer Ram Aiyar, Ph.D., MBA, to Present at 2021 Jefferies Virtual Healthcare Conference
5/25/2021
Korro Bio, Inc. , an RNA editing company focused on the discovery and development of novel genetic medicines, today announced that Ram Aiyar, Ph.D., MBA, chief executive officer, will present at the 2021 Jefferies Virtual Healthcare Conference on June 4, 2021, at 2:30 p.m. EDT.
-
Korro Bio Appoints Vineet Agarwal as Chief Financial Officer
5/11/2021
Korro Bio, Inc ., an RNA editing company focused on the discovery and development of novel genetic medicines, today announced the appointment of Vineet Agarwal as Chief Financial Officer.
-
Korro Bio Strengthens Leadership Team With Appointment of Howard Stern M.D., Ph.D. as Chief Scientific Officer
4/1/2021
Korro Bio, Inc. , an RNA editing company focused on the discovery and development of novel genetic medicines, today announced the appointment of Howard Stern, M.D., Ph.D. as Chief Scientific Officer. Dr. Stern is a seasoned biotechnology executive with extensive experience in drug discovery and development,
-
Korro Bio Chief Executive Officer Ram Aiyar, Ph.D., MBA, to Present at Upcoming Conferences
3/5/2021
Korro Bio, Inc. , a biotechnology company developing single-base RNA editing therapies, today announced that Ram Aiyar, Ph.D., MBA, chief executive officer, will present at the Barclays Global Healthcare Conference and the WuXi Healthcare Forum this month.
-
Korro Bio to Present at J.P. Morgan Healthcare Conference
1/7/2021
Korro Bio, Inc. , a biotechnology company developing single-base RNA editing therapies, today announced that Ram Aiyar, Ph.D., MBA, chief executive officer, will present an update on Korro’s progress at the 39 th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Thursday, January 14, 2021 at 8:05 a.m. E.T. using a virtual platform. About Korro Bio, Inc. Korro is leading the
-
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that recently launched.